Search results
- 1.0317344 - ÚŽFG 2009 RIV CZ cze J - Journal Article
Holubová, Monika - Strnádel, Ján - Usvald, Dušan - Klaudy, Jiří - Plánská, Daniela - Vannucci, Luca - Váňa, Petr - Reisnerová, H. - Jílek, F. - Horák, Vratislav
Terapeutická a patologická fúze nádorových buněk s imunitními buňkami - nádorové vakcíny versus nádorové hybridy.
[Therapeutical and pathological fusion of tumour cells with immune cells – tumour vaccines versus tumour hybrids.]
Bioprospect. Roč. 18, č. 3 (2008), s. 39-41. ISSN 1210-1737
R&D Projects: GA MŠMT 2B08063
Institutional research plan: CEZ:AV0Z50450515; CEZ:AV0Z50200510
Keywords : tumour vaccines
Subject RIV: FD - Oncology ; Hematology
Permanent Link: http://hdl.handle.net/11104/0167014 - 2.0191678 - UMG-J 20033193 RIV GR eng J - Journal Article
Bubeník, Jan
Tumour MHC class I downregulation and immunotherapy (Review).
Oncology Reports. Roč. 10, č. 6 (2003), s. 2005-2008. ISSN 1021-335X. E-ISSN 1791-2431
R&D Projects: GA MZd NC7148; GA ČR GA301/01/0985; GA AV ČR IAA5052203
Institutional research plan: CEZ:AV0Z5052915
Keywords : tumour vaccines * MHC class I downregulation
Subject RIV: FD - Oncology ; Hematology
Impact factor: 1.256, year: 2003
Permanent Link: http://hdl.handle.net/11104/0087416 - 3.0191666 - UMG-J 20033177 RIV CZ eng J - Journal Article
Šímová, Jana - Mikyšková, Romana - Vonka, V. - Bieblová, Jana - Bubeník, Jan - Jandlová, Táňa
MHC class I+ and class I(-)HPV16-associated tumours expressing the E7 oncoprotein do not cross-react in immunization/challenge experiments.
Folia Biologica. Roč. 2003, č. 49 (2003), s. 230-234. ISSN 0015-5500. E-ISSN 0015-5500
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV 16 * MHC class I expression * tumour vaccines
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 0.527, year: 2003
Permanent Link: http://hdl.handle.net/11104/0087404 - 4.0191662 - UMG-J 20033173 RIV GR eng J - Journal Article
Indrová, Marie - Bubeník, Jan - Mikyšková, Romana - Vonka, V. - Šmahel, M. - Žák, R. - Šímová, Jana - Bieblová, Jana - Mendoza, Luis - Jandlová, Táňa
Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin.
International Journal of Oncology. Roč. 2002, č. 20 (2002), s. 643-646. ISSN 1019-6439. E-ISSN 1791-2423
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV16, IL-2 * tumour vaccines * gene therapy
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 2.931, year: 2002
Permanent Link: http://hdl.handle.net/11104/0087400 - 5.0191426 - UMG-J 20010498 RIV US eng J - Journal Article
Bubeník, Jan - Šímová, Jana - Vonka, V. - Šmahel, M. - Mikyšková, Romana - Mendoza, Luis
Dendritic cell-based vaccines for therapy of HPV16-induced tumours.
Advances in Experimental Medicine and Biology. Roč. 495, - (2001), s. 359-363. ISSN 0065-2598. E-ISSN 2214-8019
R&D Projects: GA MZd NC5526; GA ČR GA312/98/0826; GA ČR GA312/99/0542; GA ČR GA301/00/0114; GA ČR GA301/01/0985; GA AV ČR IAA7052002
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV16 * dendritic cells * tumour vaccines
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 0.513, year: 2000
Permanent Link: http://hdl.handle.net/11104/0087179 - 6.0191425 - UMG-J 20010497 RIV US eng J - Journal Article
Indrová, Marie - Mendoza, Luis - Reiniš, Milan - Vonka, V. - Šmahel, M. - Němečková, Š. - Jandlová, Táňa - Bubeník, Jan
Bone marrow dendritic cell-based anticancer vaccines.
Advances in Experimental Medicine and Biology. Roč. 495, - (2001), s. 355-358. ISSN 0065-2598. E-ISSN 2214-8019
R&D Projects: GA MZd NC5526; GA ČR GA312/98/0826; GA ČR GA312/99/0542; GA ČR GA301/00/0114; GA ČR GA301/01/0985; GA AV ČR IAA7052002
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV16 * dendritic cells * tumour vaccines
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 0.513, year: 2000
Permanent Link: http://hdl.handle.net/11104/0087178 - 7.0191413 - UMG-J 20010485 RIV GR eng J - Journal Article
Bubeník, Jan
Animal models for development of therapeutic HPV16 vaccines.
International Journal of Oncology. Roč. 20, č. 1 (2002), s. 207-212. ISSN 1019-6439. E-ISSN 1791-2423
Institutional research plan: CEZ:AV0Z5052915
Keywords : human papilloma viruses * tumour vaccines
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 2.931, year: 2002
Permanent Link: http://hdl.handle.net/11104/0087166 - 8.0191173 - UMG-J 20010242 RIV GR eng J - Journal Article
Indrová, Marie - Bubeník, Jan - Šímová, Jana - Vonka, V. - Němečková, Š. - Mendoza, Luis - Reiniš, Milan
Therapy of HPV 16-associated carcinoma with dendritic cell-based vaccines: In vitro priming of the effector cell responses by DC pulsed with tumour lysates and synthetic RAHYNIVTF peptide.
International Journal of Molecular Medicine. Roč. 7, č. 1 (2001), s. 97-100. ISSN 1107-3756. E-ISSN 1791-244X
R&D Projects: GA MZd NC5526; GA MZd NC45011; GA ČR GA312/98/0826; GA ČR GA312/99/0542; GA ČR GA301/00/0114; GA AV ČR IAA7052002
Institutional research plan: CEZ:AV0Z5052915
Keywords : tumour vaccines * HPV16 * dendritic cells
Subject RIV: FD - Oncology ; Hematology
Impact factor: 1.689, year: 2001
Permanent Link: http://hdl.handle.net/11104/0086930 - 9.0191157 - UMG-J 20010219 RIV GR eng J - Journal Article
Bubeník, Jan
Genetically engineered dendritic cell-based cancer vaccines.
International Journal of Oncology. Roč. 18, č. 3 (2001), s. 475-478. ISSN 1019-6439. E-ISSN 1791-2423
R&D Projects: GA MZd NC5526
Keywords : dendritic cells * tumour vaccines
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 2.330, year: 2001
Permanent Link: http://hdl.handle.net/11104/0086914 - 10.0105309 - UMG-J 20043097 CA eng J - Journal Article
Bubeník, Jan - Šímová, Jana - Mikyšková, Romana - Vonka, V.
Therapy of MHC Class I+ and Class I- HPV 16-Associated Tumours with Cytokines, Genetically Modified Tumour Vaccines and Dendritic Cells.
Clinical and Investigative Medicine. Roč. 27, č. 4 (2004), s. 161D. ISSN 0147-958X. E-ISSN 1488-2353.
[International Congress of Immunology /12./ and Annual Conference of FOCIS /4./. Montreal, 18.07.2004-23.07.2004]
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV 16 * tumour vaccines * dendritic cells
Subject RIV: EC - Immunology
Impact factor: 1.051, year: 2004
Permanent Link: http://hdl.handle.net/11104/0012553